TVARDI THERAPEUTICS, INC. (TVRD) Free cash flow 2016–2024
TVARDI THERAPEUTICS, INC. (TVRD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$19.4MFY2024 · since FY2016: -$48.1M → -$19.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$19.4M | +79.5% |
| FY2023 | -$94.5M | -19.9% |
| FY2022 | -$78.8M | -31.0% |
| FY2021 | -$60.1M | -930.3% |
| FY2020 | -$5.8M | +94.7% |
| FY2019 | -$109.2M | -388.3% |
| FY2018 | -$22.4M | +59.2% |
| FY2017 | -$54.9M | -14.1% |
| FY2016 | -$48.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TVRD financial trends
TVRD RevenueTVRD Net incomeTVRD Net marginTVRD Gross profitTVRD Gross marginTVRD Operating incomeTVRD Operating marginTVRD Operating cash flowTVRD Capital expendituresTVRD Return on equityTVRD Stock buybacksTVRD Dividends paidTVRD Total assetsTVRD Total liabilitiesTVRD Shareholders’ equityTVRD overview →